Pharmaplast SAE

FDA inspection history in Alexandria, Egypt, 2022 to 2023

1
Warning letter
1
Form 483

Every document, by year

  • Warning letter
  • Form 483

2022: one Form 483; 2023: one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2022–23One Form 483 and one warning letter, at Alexandria, Egypt.

Cited most

Across all Pharmaplast SAE observations on file

The complete Pharmaplast SAE file.

All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$198

The price of the documents, added to your cart together

Sites

Documents

2 on file, newest first
DateDocumentPrice
2023-04-13Warning letter Warning letter$99
2022-11-10483 Form 483$99

Investigators on these documents

Michael A. Charles (1)

FEI number 3003767891 · most recent document Apr 13, 2023

About Pharmaplast SAE

How many FDA Form 483s has Pharmaplast SAE received?

FDA Intel has 1 Form 483 on file for Pharmaplast SAE; the most recent is dated Nov 10, 2022.

When was Pharmaplast SAE last inspected by FDA?

The most recent FDA inspection document on file for Pharmaplast SAE is a Form 483 dated Nov 10, 2022, for the site in Alexandria, Egypt.

What did FDA cite at Pharmaplast SAE?

The regulations cited most in the observations on file for Pharmaplast SAE are 21 CFR 211.188(b) (Batch production and control records), 2 times; 21 CFR 211, 1 time; 21 CFR 211.165(a) (Testing and release for distribution), 1 time.

Has Pharmaplast SAE received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Pharmaplast SAE; the most recent is dated Apr 13, 2023.